These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Management of anemia using recombinant human erythropoietin in patients on chronic hemodialysis.
    Author: Cotton SL, Holechek MJ.
    Journal: ANNA J; 1989 Dec; 16(7):463-8. PubMed ID: 2604448.
    Abstract:
    Most hemodialysis patients experience symptomatic anemia related to their chronic renal failure that can limit physical activities, interfere with rehabilitation, and negatively affect the quality of life. Preliminary studies of the newly developed recombinant human erythropoietin (rHuEPO) have revealed that this drug can correct the anemia of chronic renal failure and alleviate many of its related symptoms. This article reviews the pathophysiology of this anemia, discusses rHuEPO, describes the nursing care of patients receiving rHuEPO, and considers future implications and areas for nursing research.
    [Abstract] [Full Text] [Related] [New Search]